OCEANSIDE, CA – AOTI, Inc., a medical technology company specializing in wound healing and amputation prevention, has awarded its Chief Financial Officer, Jayesh Pankhania, a significant number of performance-based share options under its Long Term Incentive Plan (LTIP). The grant, which took place today, involves 208,333 ordinary shares with an exercise price set at a nominal $0.00001 per share.
The performance share awards are tied to rigorous three-year goals, with 40% depending on revenue growth, 30% on relative total shareholder return (TSR) against a peer group, and the remaining 30% on absolute TSR. The relative TSR will be measured against companies from the UK, US, and other international markets, with vesting ranging from median to upper quartile performance. Absolute TSR vesting will begin at 10% compound annual growth, increasing to full vesting at 20% compound annual growth.
This incentive aligns with AOTI’s mission to deliver cost-effective and quality-of-life-enhancing solutions for patients with severe and chronic wounds. The company’s Topical Wound Oxygen (TWO2®) therapy has been clinically proven to significantly reduce hospitalizations and amputations associated with Diabetic Foot Ulcers (DFUs).
AOTI, founded in 2006 and headquartered in Oceanside, California, and Galway, Ireland, has received regulatory clearances for its TWO2® therapy in multiple regions, including the US, Europe, the UK, Canada, China, Australia, and Saudi Arabia.
The performance awards will vest on December 17, 2027, provided the set conditions are met. The LTIP aims to incentivize key management personnel to pursue the company’s long-term growth objectives.
The announcement comes as AOTI continues to push the boundaries of medical technology in wound care, leveraging its patented solutions to address a critical healthcare need globally. The performance conditions set forth for the CFO’s awards underscore the company’s commitment to growth and shareholder value.
This report is based on a press release statement from AOTI, Inc. and does not include any promotional content or subjective claims. The information provided is intended to offer a clear and factual account of the LTIP awards granted to the company’s CFO.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
